Centrica Lowered to Neutral at HSBC (CNA)
Centrica (LON:CNA) was downgraded by equities research analysts at HSBC from an “overweight” rating to a “neutral” rating in a research note issued to investors on Monday, StockRatingsNetwork.com reports. They currently have a GBX 400 ($6.39) price objective on the stock, down from their previous price objective of GBX 440 ($7.02). HSBC’s target price points to a potential upside of 11.51% from the company’s current price.
A number of other firms have also recently commented on CNA. Analysts at Citigroup Inc. reiterated a “neutral” rating on shares of Centrica in a research note to investors on Monday, October 7th. They now have a GBX 390 ($6.23) price target on the stock. Separately, analysts at AlphaValue reiterated an “add” rating on shares of Centrica in a research note to investors on Thursday, October 3rd. They now have a GBX 433 ($6.91) price target on the stock. Finally, analysts at BNP Paribas reiterated an “underperform” rating on shares of Centrica in a research note to investors on Wednesday, October 2nd. They now have a GBX 310 ($4.95) price target on the stock. Five investment analysts have rated the stock with a sell rating, twelve have given a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. Centrica currently has an average rating of “Hold” and a consensus target price of GBX 385.66 ($6.16).
Centrica (LON:CNA) traded down 1.27% on Monday, hitting GBX 358.70. 9,172,761 shares of the company’s stock traded hands. Centrica has a 52-week low of GBX 308.80 and a 52-week high of GBX 403.20. The stock has a 50-day moving average of GBX 391.8 and a 200-day moving average of GBX 377.4. The company’s market cap is £18.584 billion.
Centrica plc is an integrated energy company. The Company operates in four segments: Downstream UK, Upstream UK, Storage UK and North America.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.